肺栓塞患者入院临床标志物与病情严重程度的相关性研究
A Study on the Correlation between Clinical Markers at Admission and the Severity of Pulmonary Embolism in Patients
DOI: 10.12677/acm.2026.1641480, PDF,   
作者: 向远群:右江民族医学院研究生学院,广西 百色;李 丽:百色市人民医院,广西 百色
关键词: 肺栓塞临床标志物危险分层病情严重程度预后评估Pulmonary Embolism Clinical Biomarkers Risk Stratification Disease Severity Prognosis Assessment
摘要: 目的:系统综述肺栓塞患者入院时临床标志物与病情严重程度的相关性,为临床危险分层和预后评估提供依据。方法:通过文献检索和分析,探讨白细胞、中性粒细胞、血小板、红细胞计数、纤维蛋白原、D-二聚体、血糖、超敏C反应蛋白、白介素-6、高敏肌钙蛋白、脑钠肽、中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值等临床标志物在肺栓塞危险分层中的应用价值。结果:多种临床标志物与肺栓塞病情严重程度显著相关,其中炎症标志物(如系统免疫炎症指数、中性粒细胞/淋巴细胞比值)、心肌损伤标志物(肌钙蛋白、脑钠肽)、凝血功能标志物(D-二聚体、纤维蛋白原)以及营养状态标志物(白蛋白、前白蛋白)均在危险分层中具有重要价值。联合检测多项标志物可提高对肺栓塞严重程度的评估准确性和预后预测能力。结论:临床标志物在肺栓塞患者的危险分层和预后评估中发挥重要作用,多指标联合应用可为临床决策提供更可靠的依据,特别适用于缺乏高级检查设备的基层医疗机构。
Abstract: Objective: To systematically review the correlation between clinical biomarkers at admission and disease severity in patients with pulmonary embolism, providing evidence for clinical risk stratification and prognosis assessment. Methods: Through literature retrieval and analysis, we explored the application value of clinical biomarkers including white blood cells, neutrophils, platelets, red blood cell count, fibrinogen, D-dimer, blood glucose, high-sensitivity C-reactive protein, interleukin-6, high-sensitivity troponin, brain natriuretic peptide, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in risk stratification of pulmonary embolism. Results: Multiple clinical biomarkers were significantly correlated with the severity of pulmonary embolism. Inflammatory markers (such as systemic immune-inflammation index, neutrophil-to-lymphocyte ratio), myocardial injury markers (troponin, brain natriuretic peptide), coagulation function markers (D-dimer, fibrinogen), and nutritional status markers (albumin, prealbumin) all demonstrated important value in risk stratification. Combined detection of multiple biomarkers can improve the accuracy of severity assessment and prognosis prediction in pulmonary embolism. Conclusion: Clinical biomarkers play an important role in risk stratification and prognosis assessment of patients with pulmonary embolism. Multi-marker combined application can provide more reliable evidence for clinical decision-making, particularly suitable for primary healthcare institutions lacking advanced examination equipment.
文章引用:向远群, 李丽. 肺栓塞患者入院临床标志物与病情严重程度的相关性研究[J]. 临床医学进展, 2026, 16(4): 2318-2327. https://doi.org/10.12677/acm.2026.1641480

参考文献

[1] 张俊华, 张卉卉, 王华英. 血清前白蛋白及新型炎症指标与急性肺栓塞风险分层的相关性分析[J]. 现代实用医学, 2025, 37(10): 1068-1071.
[2] Konstantinides, S.V., Meyer, G., Becattini, C., Bueno, H., Geersing, G., Harjola, V., et al. (2020) 2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration with the European Respiratory Society (ERS). European Heart Journal, 41, 543-603. [Google Scholar] [CrossRef] [PubMed]
[3] 白春兰, 孙亚召, 孟杰杰, 等. 系统免疫炎症指数和胱抑素C在急性肺栓塞病情严重程度及预后评估中的应用[J]. 心血管康复医学杂志, 2025, 34(3): 310-317.
[4] Righini, M., Robert-Ebadi, H. and Le Gal, G. (2024) Age-Adjusted and Clinical Probability Adapted D-Dimer Cutoffs to Rule Out Pulmonary Embolism: A Narrative Review of Clinical Trials. Journal of Clinical Medicine, 13, Article 3441. [Google Scholar] [CrossRef] [PubMed]
[5] 宋建霞, 杨越, 陈蓉, 等. 急性肺栓塞患者预后评估研究进展[J]. 分子影像学杂志, 2025, 48(7): 905-910.
[6] 钟培雄, 陈钰, 郝金香, 等. 血浆SCUBE-1、ADAMTS-9及ANG-2水平预测急性肺栓塞严重程度及预后的价值[J]. 广东医学, 2024, 45(8): 998-1003.
[7] 邢芳远, 郭小霞, 郭瑞霞. MLPR、NLR、RDW对老年AECOPD患者合并肺栓塞的评估价值[J]. 分子诊断与治疗杂志, 2024, 16(4): 599-603.
[8] 张倩, 赵敏, 马威. 急性肺栓塞患者血清内源性配体-13与生长分化因子-15及葡萄糖调节蛋白78水平与临床预后相关性[J]. 社区医学杂志, 2024, 22(5): 148-153.
[9] 臧传丽, 朴玉华, 朴红梅. 单核细胞计数与高密度脂蛋白比值及全身免疫炎症指数预测急性肺栓塞病情严重程度及预后的临床意义[J]. 延边大学医学学报, 2023, 46(4): 276-281.
[10] Konstantinides, S.V., Meyer, G., Becattini, C., Bueno, H., Geersing, G., Harjola, V., et al. (2019) 2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration with the European Respiratory Society (ERS). European Respiratory Journal, 54, Article ID: 1901647. [Google Scholar] [CrossRef] [PubMed]
[11] Huisman, M.V., Barco, S., Cannegieter, S.C., Le Gal, G., Konstantinides, S.V., Reitsma, P.H., et al. (2018) Pulmonary Embolism. Nature Reviews Disease Primers, 4, Article No. 18028. [Google Scholar] [CrossRef] [PubMed]
[12] Keller, K., Hobohm, L., Ebner, M., Kresoja, K., Münzel, T., Konstantinides, S.V., et al. (2020) Trends in Thrombolytic Treatment and Outcomes of Acute Pulmonary Embolism in Germany. European Heart Journal, 41, 522-529. [Google Scholar] [CrossRef] [PubMed]
[13] Giri, J., Sista, A.K., Weinberg, I., Kearon, C., Kumbhani, D.J., Desai, N.D., et al. (2019) Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement from the American Heart Association. Circulation, 140, 774-801. [Google Scholar] [CrossRef] [PubMed]
[14] 李德志, 朱玲. 危险分层对肺栓塞管理策略的指导价值[J]. 中国临床新医学, 2021, 14(4): 340-344.
[15] Joyce, E., McMullen, J., Kong, X., O’Hare, C., Gavrila, V., Cuttitta, A., et al. (2025) Performance of an Electronic Health Record-Based Automated Pulmonary Embolism Severity Index Score Calculator: Cohort Study in the Emergency Department. JMIR Medical Informatics, 13, e58800. [Google Scholar] [CrossRef] [PubMed]
[16] Maraziti, G., Cimini, L.A. and Becattini, C. (2022) Risk Stratification to Optimize the Management of Acute Pulmonary Embolism. Expert Review of Cardiovascular Therapy, 20, 377-387. [Google Scholar] [CrossRef] [PubMed]
[17] Liao, Y., Yang, C. and Bakeer, B. (2021) Prognostic Value of Red Blood Cell Distribution Width in Patients with Acute Pulmonary Embolism: A Protocol for Systematic Review and Meta-Analysis. Medicine, 100, e25571. [Google Scholar] [CrossRef] [PubMed]
[18] Igneri, L.A. and Hammer, J.M. (2020) Systemic Thrombolytic Therapy for Massive and Submassive Pulmonary Embolism. Journal of Pharmacy Practice, 33, 74-89. [Google Scholar] [CrossRef] [PubMed]
[19] Özdemir, L., Özdemir, B., Gegin, S., Aksu, E. and Pazarlı, A. (2025) Can Systemic Inflammatory Markers Be Used in Pulmonary Embolism Risk Assessment in Patients with Acute Pulmonary Thromboembolism? Journal of Inflammation Research, 18, 5969-5977. [Google Scholar] [CrossRef] [PubMed]
[20] Zuin, M., Bilato, C., Quadretti, L., Vatrano, M., Navaro, M., Rigatelli, G., et al. (2022) Tasso di embolia polmonare acuta nei pazienti ospedalizzati per COVID-19 in Italia. Metanalisi aggregata [Incidence of Acute Pulmonary Embolism in Hospitalized COVID-19 Italian Patients. A Pooled Meta-Analysis]. Giornale Italiano di Cardiologia, 23, 233-243. [Google Scholar] [CrossRef] [PubMed]
[21] Franchin, L. and Iannaccone, M. (2025) Limitations and Future Perspectives on Pulmonary Embolism: So Far, So Good. Interventional Cardiology: Reviews, Research, Resources, 20, e11. [Google Scholar] [CrossRef] [PubMed]
[22] Leidi, A., Bex, S., Righini, M., Berner, A., Grosgurin, O. and Marti, C. (2022) Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives. Journal of Clinical Medicine, 11, Article 2533. [Google Scholar] [CrossRef] [PubMed]
[23] Barnes, G.D., Muzikansky, A., Cameron, S., Giri, J., Heresi, G.A., Jaber, W., et al. (2020) Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response Teams. JAMA Network Open, 3, e2010779. [Google Scholar] [CrossRef] [PubMed]
[24] Zahorec, R. (2021) Neutrophil-To-Lymphocyte Ratio, Past, Present and Future Perspectives. Bratislava Medical Journal, 122, 474-488. [Google Scholar] [CrossRef] [PubMed]
[25] Fest, J., Ruiter, R., Ikram, M.A., Voortman, T., van Eijck, C.H.J. and Stricker, B.H. (2018) Reference Values for White Blood-Cell-Based Inflammatory Markers in the Rotterdam Study: A Population-Based Prospective Cohort Study. Scientific Reports, 8, Article No. 10566. [Google Scholar] [CrossRef] [PubMed]
[26] Akpinar, E.E., Hoşgün, D., Akpinar, S., et al. (2020) Platelet-To-Lymphocyte Ratio and Neutrophil-To-Lymphocyte Ratio Predict In-Hospital Mortality in Patients with Pulmonary Embolism. International Angiology, 39, 430-437.
[27] 王渝胜, 王华蕊, 朱玲. sPESI联合RDW和NLR对急性非高危肺栓塞患者预后的预测价值[J]. 中国急救医学, 2021, 41(4): 302-306.
[28] Wang, B., Huang, Y. and Lin, T. (2020) Prognostic Impact of Elevated Pre-Treatment Systemic Immune-Inflammation Index (SII) in Hepatocellular Carcinoma: A Meta-Analysis. Medicine, 99, e18571. [Google Scholar] [CrossRef] [PubMed]
[29] Fois, A.G., Paliogiannis, P., Scano, V., Cau, S., Babudieri, S., Perra, R., et al. (2020) The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules, 25, Article 5725. [Google Scholar] [CrossRef] [PubMed]
[30] Levi, M. and van der Poll, T. (2017) Coagulation and Sepsis. Thrombosis Research, 149, 38-44. [Google Scholar] [CrossRef] [PubMed]
[31] Dömer, D., Walther, T., Möller, S., Behnen, M. and Laskay, T. (2021) Neutrophil Extracellular Traps Activate Proinflammatory Functions of Human Neutrophils. Frontiers in Immunology, 12, Article 636954. [Google Scholar] [CrossRef] [PubMed]
[32] Podd, B.S., Banks, R.K., Reeder, R., Telford, R., Holubkov, R., Carcillo, J., et al. (2023) Early, Persistent Lymphopenia Is Associated with Prolonged Multiple Organ Failure and Mortality in Septic Children. Critical Care Medicine, 51, 1766-1776. [Google Scholar] [CrossRef] [PubMed]
[33] López-Moreno, M., Garcés-Rimón, M., Miguel-Castro, M., Fernández-Martínez, E. and Iglesias López, M.T. (2023) Effect of Nutrition Education on Health Science University Students to Improve Cardiometabolic Profile and Inflammatory Status. Nutrients, 15, Article 4685. [Google Scholar] [CrossRef] [PubMed]
[34] Cheng, W., Kong, F. and Chen, S. (2022) Comparison of the Predictive Value of Four Insulin Resistance Surrogates for the Prevalence of Hypertension: A Population-Based Study. Diabetology & Metabolic Syndrome, 14, Article No. 137. [Google Scholar] [CrossRef] [PubMed]
[35] 李惠萍, 胡安民, 高伟, 等. 单核细胞计数/高密度脂蛋白胆固醇比值与急性肺栓塞的相关性[J]. 中国医科大学学报, 2022, 51(2): 131-135.
[36] Noushad, S., Ahmed, S., Ansari, B., Mustafa, U.H., Saleem, Y. and Hazrat, H. (2021) Physiological Biomarkers of Chronic Stress: A Systematic Review. International Journal of Health Sciences, 15, 46-59.
[37] Ozcan, S., Donmez, E., Tuğrul, S.Y., Şahin, İ., İnce, O., Ziyrek, M., et al. (2022) The Prognostic Value of C-Reactive Protein/Albumin Ratio in Acute Pulmonary Embolism. Revista de Investigación Clínica, 74, 97-103. [Google Scholar] [CrossRef] [PubMed]
[38] Tayal, D., Jain, P. and Goswami, B. (2024) D-Dimer—A Multifaceted Molecule. Hormone Molecular Biology and Clinical Investigation, 45, 75-84. [Google Scholar] [CrossRef] [PubMed]
[39] 张庭强, 黄凯丽, 李多. 纤维蛋白原/白蛋白比值联合肺栓塞严重程度指数在急性肺血栓栓塞患者的病情诊断和预后评估的价值[J]. 中国呼吸与危重监护杂志, 2023, 22(12): 858-862.
[40] 赵贺红, 李群. 不同病情严重程度急性肺栓塞患者血清和肽素、白细胞介素-38、单核细胞计数/高密度脂蛋白胆固醇、D-二聚体/纤维蛋白原变化及预后影响因素分析[J]. 陕西医学杂志, 2023, 52(9): 1186-1190.
[41] Elmewafy, A.T., Waller, J., Alaguraja, P., Desor, K. and Antoun, I. (2025) The Prognostic Value of Troponin in Acute Pulmonary Embolism: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions, 106, 3899-3916. [Google Scholar] [CrossRef
[42] 李佩佩, 马耿, 齐娜, 等. 老年中、高危肺栓塞肺动脉压力变化趋势及其与预后的相关性[J]. 中国老年学杂志, 2022, 42(16): 3947-3950.
[43] 潘婷, 夏蕾, 石容容, 等. CT肺动脉造影结合血清学标志物在急性肺栓塞诊断中的应用[J]. 中国CT和MRI杂志, 2023, 21(4): 67-69.
[44] Elshahaat, H.A., Zayed, N.E., Ateya, M.A., Safwat, M., El Hawary, A.T. and Abozaid, M.N. (2023) Role of Serum Biomarkers in Predicting Management Strategies for Acute Pulmonary Embolism. Heliyon, 9, e21068. [Google Scholar] [CrossRef] [PubMed]
[45] Irmak, I., Sertçelik, Ü., Öncel, A., Er, B., İnam, G., Durhan, G., Demir, A. and Çöplü, L. (2020) Correlation of Trombosed Vessel Location and Clot Burden Score with Severity of Disease and Risk Stratification in Patients with Acute Pulmonary Embolism. The Anatolian Journal of Cardiology, 24, 247-253. [Google Scholar] [CrossRef] [PubMed]
[46] Katsioupa, M., Kourampi, I., Oikonomou, E., Tsigkou, V., Theofilis, P., Charalambous, G., et al. (2023) Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome. Life, 13, Article 1992. [Google Scholar] [CrossRef] [PubMed]
[47] Soeters, P.B., Wolfe, R.R. and Shenkin, A. (2019) Hypoalbuminemia: Pathogenesis and Clinical Significance. Journal of Parenteral and Enteral Nutrition, 43, 181-193. [Google Scholar] [CrossRef] [PubMed]
[48] 陈安琪, 吴云. 血清清蛋白与急性肺栓塞危险分层及短期预后的关系[J]. 中西医结合心脑血管病杂志, 2024, 22(5): 911-914.
[49] 黄凯丽, 舒泸莹, 周晓莲, 等. 前白蛋白、白蛋白与D-二聚体在急性肺栓塞病情严重程度及预后中的预测价值[J]. 广西医科大学学报, 2023, 40(7): 1206-1211.
[50] Hamzah, A. and Dawood, T. (2024) Effect of Selenium Nanoparticle on Lipid Profile in Local Awassi Male Lambs. Open Veterinary Journal, 14, 1161-1166. [Google Scholar] [CrossRef] [PubMed]
[51] 陈锦春, 高国生, 范玲燕. 血清载脂蛋白A1在肺栓塞中的临床价值[J]. 中国现代医生, 2023, 61(25): 27-30.
[52] Ravn, B., Prowle, J.R., Mårtensson, J., Martling, C. and Bell, M. (2017) Superiority of Serum Cystatin C over Creatinine in Prediction of Long-Term Prognosis at Discharge from ICU. Critical Care Medicine, 45, e932-e940. [Google Scholar] [CrossRef] [PubMed]
[53] 吴小燕, 钱仁怡, 吕玲春, 等. 尿酸与呼吸系统疾病相关性的研究进展[J]. 浙江实用医学, 2024, 29(1): 86-90.
[54] Natanzon, S.S., Mansour, M., Fardman, A., Chernomordik, F., Herscovici, R., Matetzky, S., et al. (2025) Intermediate-risk Pulmonary Embolism: Patients’ Stratification, Prognosis, and Therapeutic Options—Time to Pay Attention to the Middle Child. Journal of Clinical Medicine, 14, Article 6215. [Google Scholar] [CrossRef
[55] Zhu, N., Zhang, L., Lin, S., Mao, F., Cao, C. and Chen, L. (2026) Innovative Inflammatory Burden Index for Identification of High Mortality Risk in Patients with Pulmonary Embolism: A Large Retrospective Cohort Study. BMJ Open Respiratory Research, 13, e003743. [Google Scholar] [CrossRef
[56] 王震, 白佳玉, 李澎, 等. SIRI、AISI和SII对急性肺栓塞的诊断和危险分层的预测价值[J]. 解放军医学院学报, 2024, 45(1): 53-58, 66.
[57] Jia, D., Liu, F., Zhang, Q., Zeng, G., Li, X. and Hou, G. (2018) Rapid On‐Site Evaluation of Routine Biochemical Parameters to Predict Right Ventricular Dysfunction in and the Prognosis of Patients with Acute Pulmonary Embolism Upon Admission to the Emergency Room. Journal of Clinical Laboratory Analysis, 32, e22362. [Google Scholar] [CrossRef] [PubMed]
[58] 陈凤莲, 朱青蓝, 陈国飞. NT-proBNP、肌钙蛋白I及D-二聚体水平与急性心肌梗死心功能相关性研究[J]. 中外医学研究, 2025, 23(6): 134-137.